Average Co-Inventor Count = 7.14
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Research Technology Limited (15 from 263 patents)
2. The Institute of Cancer Research: Royal Cancer Hospital (3 from 51 patents)
3. The Institute of Cancer Research (1 from 24 patents)
15 patents:
1. 12486285 - BCL6 inhibitors
2. 12110286 - Benzimidazolone derived inhibitors of BCL6
3. 11897877 - Inhibitor compounds
4. 11512095 - BCL6 inhibitors
5. 11161839 - 2-quinolone derived inhibitors of BCL6
6. 11046688 - Inhibitor compounds
7. 10479788 - Compounds that inhibit MPS1 kinase
8. 10399974 - N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
9. 10188642 - Pharmacologically active compounds
10. 9902721 - N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors
11. 9895364 - Pharmacologically active compounds
12. 9890157 - Inhibitor compounds
13. 9834552 - Inhibitor compounds
14. 9409907 - Inhibitor compounds
15. 9334286 - Pharmacologically active compounds